Dr. Feldman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3330 N 2nd St
Suite 300
Phoenix, AZ 85012Phone+1 602-274-7195Fax+1 602-274-7097- Is this information wrong?
Summary
- I have dedicated the past 20 years to pulmonary vascular disease and advanced lung disease.
I have created educational websites for pulmonary hypertension (pulmonaryhypertensionRN.com) and pulmonary fibrosis (pulmonaryfibrosisMD.com)
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2004
- Brigham and Women's HospitalResidency, Internal Medicine, 1998 - 2001
- University of California San Diego School of MedicineClass of 1998
Certifications & Licensure
- AZ State Medical License 2004 - 2025
- CA State Medical License 2001 - 2024
- OR State Medical License 2021 - 2023
- MA State Medical License 2000 - 2004
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Clinical Trials
- Study in Subjects With PAH and PH Secondary to IPF Using Inhaled GeNOsyl. Start of enrollment: 2011 Mar 01
- Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies Start of enrollment: 2010 Dec 01
- Phase III Clinical Worsening Study of UT-15C in Subjects With PAH Receiving Background Oral Monotherapy Start of enrollment: 2012 Jun 26
- Join now to see all
Publications & Presentations
PubMed
- AV-101, a novel inhaled dry-powder formulation of imatinib, in healthy adult participants: a phase 1 single and multiple ascending dose study.Hunter Gillies, Ralph Niven, Benjamin T Dake, Murali M Chakinala, Jeremy P Feldman, Nicholas S Hill, Marius M Hoeper, Marc Humbert, Vallerie V McLaughlin, Martin Kankam> ;ERJ Open Research. 2023 Mar 1
- Pulmonary artery compliance in different forms of pulmonary hypertension.Amber McCormick, Amita Krishnan, David Badesch, Raymond L Benza, Todd M Bull, Teresa De Marco, Jeremy Feldman, Anna R Hemnes, Russel Hirsch, Evelyn Horn, Jaime Kennedy...> ;Heart. 2023 Feb 14
- Erratum: Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: An analysis of the Pulmonary Hypert...Hilary M DuBrock, Charles D Burger, Sonja D Bartolome, Jeremy P Feldman, David D Ivy, Erika B Rosenzweig, Jeffrey S Sager, Kenneth W Presberg, Stephen C Mathai, Matthe...> ;Pulmonary Circulation. 2022 Oct 1
- Join now to see all
Press Mentions
- New Pulmonary Hypertension Association Accreditation Program and Registry Giving New Understanding to Specialists Caring for People Living with Pulmonary HypertensionFebruary 3rd, 2017
- Phase 3 INOpulse Trial Enrolls First Patient at Risk of PF-Associated PHDecember 5th, 2020
- First Patient Enrolled in Phase 3 REBUILD Trial of INOpulseDecember 8th, 2020
Hospital Affiliations
- Abrazo Arizona Heart HospitalPhoenix, Arizona
- HonorHealth Scottsdale Shea Medical CenterScottsdale, Arizona
- St. Joseph's Hospital and Medical CenterPhoenix, Arizona
- HonorHealth Scottsdale Thompson Peak Medical CenterScottsdale, Arizona
- HonorHealth Deer Valley Medical CenterPhoenix, Arizona
- Phoenix Children's HospitalPhoenix, Arizona
- San Carlos Apache Healthcare CorporationPeridot, Arizona
External Links
- Pulmonary Hypertensionhttp://www.pulmonaryhypertensionRN.com
- Pulmonary Fibrosishttp://www.pulmonaryfibrosisMD.com
- Consultinghttp://JPFAdvisors.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: